| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 26 May 2026 | 18 May 2026 |
| To consider and approve the financial results for the half year and year ended on March 31, 2026, dividend and other business matters | ||
| Board Meeting | 27 Mar 2026 | 27 Mar 2026 |
| Sotac Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 27, 2026. | ||
| Board Meeting | 12 Nov 2025 | 7 Nov 2025 |
| To consider and approve the financial results for the period ended September 30, 2025 and other business matters. Sotac Pharmaceuticals Limited has submitted to the Exchange, the financial results for the half year ended September 30, 2025. (As Per NSE Announcement Dated On : 12.11.2025) | ||
| Board Meeting | 30 Aug 2025 | 30 Aug 2025 |
| Sotac Pharmaceuticals Limited has informed the Exchange regarding the approval of the 10th AGM Notice, Directors Report, AGM schedule and approved all other business as per agenda circulated. | ||
| Board Meeting | 28 May 2025 | 23 May 2025 |
| Intimation of Board meeting for consideration of Audited Standalone & Consolidated Financial Results for half year and year ended on March 31, 2025 and Audited Financial Statement of the Company for year ended on March 31, 2025, Dividend and Other Business Matter. Sotac Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 28, 2025, recommended Final Dividend of Rs. 0.10 per equity share. (As Per NSE Announcement Dated on 28.05.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
